FindTrial
Sign In

a clinical trial study the effect of exercise with drug management to drug management in quality of life in patient with interstitial lung disease

Comparisonof Pharmacotherapy alone and Pharmacotherapy with additional structured Pulmonary Rehabilitation on the quality of life of patients with Interstitial Lung Diseases in a tertiary care centreââ?¬â?? A Randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/030920
Enrollment
80
Registered
2021-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J849- Interstitial pulmonary disease, unspecified

Interventions

Intervention1: pulmonary rehabilitation for 2 months: pulmonary rehabilitation along with standard pharmacotherapy on quality of life in patients with interstitial lung disease Control Intervention1:

Sponsors

Jawaharlal Institute of Post Graduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all ILD type patient on stable medical therapy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pulmonary Rehabilitation may help in improving the exercise capacity and health related quality of life in patients with ILDTimepoint: effects of pulmonary rehabilitation assessed in 2 month and 6 month of pulmonary rehabilitation—

Secondary

MeasureTime frame
physiotherapy with standard pharmacotherapy on quality of life of patients with interstitial lung disease afterr 2 months of nterventionTimepoint: 2 months of physiotherapy followup for 6 months—

Countries

India

Contacts

Public ContactDrSivaselvi

JIPMER

mail2manju22@gmail.com9787100863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026